Biotech

All Articles

Turnstone lays off 60%, shakes up C-suite to stretch out money

.Turnstone Biologics is lowering its head count through 60% as well as shocking its C-suite so as to...

Gilead gives up on $15M MASH bet after mulling preclinical records

.In a year that has viewed an authorization and also a range of readouts for metabolic dysfunction-a...

Texas biotech axes cancer cells contract, pins wishes on weight problems

.Alaunos Therapeutics is actually axing an agreement with Precigen, surrendering licensing civil lib...

Capricor allotments even more records for DMD treatment after starting BLA

.Capricor Therapies is actually taking a triumph lap for their period 2 Duchenne muscle dystrophy (D...

FDA places Kezar lupus test in hold following 4 patient deaths

.The FDA has positioned Kezar Lifestyle Sciences' lupus trial on hold after the biotech hailed four ...

Phase 3 Scholar Rock trial attacks SMA goal, sending stockpile 200%

.A stage 3 trial of Scholar Rock's spine muscular degeneration (SMA) applicant has attacked its own ...

CAMP 4 is actually latest to eye IPO, while Upstream spells out $182M plan

.RNA biotech CAMP4 Rehabs has marked out plans for a $67 thousand IPO, along with inflammation-focus...

Galecto gets leukemia drug, falls bone cancer property in pivot

.A year after the breakdown of an idiopathic pulmonary fibrosis candidate sent Galecto on a look for...

Judo tosses down $100M to knock out renal ailment

.Taking the mat is Judo Bio, an up-and-coming biotech armed along with $100 million to build oligonu...

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has actually settled CSPC Pharmaceutical Team $one hundred million for a preclinical he...